Latest Advocacy Group Content

Latest Content

Faith, Science, and Miracles: A Conversation About CAR-T Cell Therapy with the Whitehead Family

December 4th 2020, 8:00pm

By Jessica Skarzynski


Emily Whitehead was the first child to receive chimeric antigen receptor (CAR)-T cell therapy. Eight years later, she and her parents discuss her ongoing remission from acute lymphoblastic leukemia.

Cancer, Boundaries, Safety and COVID-19 Considerations During the Holidays

December 4th 2020, 5:00pm

By Tamera Anderson-Hanna


Figuring out boundaries and safety in relation to COVID-19 has been an ongoing challenge this year, and with the holidays coming up pressure is mounting. Here is how one cancer survivor considered their boundaries this year.

Friday Frontline: Preliminary Evidence Shows Connection Between Cancer Recurrence and Stress-Related Hormones, Texas Mayor Tests Positive for COVID-19 After Cancer Diagnosis, and More

December 4th 2020, 4:00pm

By Conor Killmurray


From a recently published study showing preliminary connections between elevated levels of stress-related hormones and cancer recurrence, to a Texas mayor receiving a diagnosis of cancer and COVID-19, here’s what’s happening in the cancer landscape this week.

Evolving Standards and Heated Debates in the Treatment of Newly Diagnosed Multiple Myeloma

December 4th 2020, 2:00pm


Evolving standards of care in newly diagnosed multiple myeloma (MM) have given patients a wider variety of possibilities but can also be disconcerting. In a presentation during CURE®’s Educated Patient® Multiple Myeloma Summit, Dr. Clifton Mo, of Dana-Farber Cancer Institute, explores the treatment landscape and breaks down what these different options can offer patients.

Immunotherapy 101: What Patients Can Expect from CAR-T Cell Therapy

December 3rd 2020, 10:00pm

By Jessica Skarzynski


Chimeric antigen receptor (CAR)-T cell therapy is becoming more widely available, with two drugs approved to treat specific blood cancers and more being investigated in clinical trials across cancer types. Here’s what patients need to know if they’re considering treatment with one of these novel immunotherapies.

Vitamin D May Reduce Risk for Developing Advanced Cancer

December 3rd 2020, 7:00pm

By Darlene Dobkowski, MA


The reduced incidence in developing advanced cancer in patients at least 50 years and older was more prominent in those with normal weight vs. overweight or obesity.

The Impact of Sharing Your Cancer Story

December 3rd 2020, 5:00pm

By Kim Johnson


Your cancer story is unique to you, but sometimes the impact of sharing it can change your own perspective on the cancer journey.

The Breasties: Igniting Strength and Positivity Through Community

December 3rd 2020, 4:00pm

By Jessica Skarzynski


This week on the “CURE Talks Cancer” podcast, we discuss the power of community with The Breasties co-founders Brianna Majsiak and Allie Brudner Brumel and how their own experiences with breast cancer brought them together.

Artificial Intelligence May Accurately Predict Short-Term Mortality in Patients with Cancer

December 3rd 2020, 2:00pm

By Colleen Moretti


An artificial intelligence-based algorithm within the electronic medical record provided real-time and accurate predictions of the short-term mortality rate of patients with cancer, outperforming all other prognostic incidences commonly used.

Sponsored by Kyowa Kirin: Understanding the Ins and Outs of CTCL

December 3rd 2020, 1:00pm


Dr. Yuliya Linhares discusses cutaneous T-cell lymphoma and the role of a multidisciplinary team of specialists in designing and managing care.